As reported in a research article, 994 patients underwent aortic valve replacement between october 2011 and october 2020.Events of aortic stenosis and aortic regurgitation were reported; the trifecta valve had a 1.4% all-cause reintervention rate at 10 years, with insignificant impact on survival.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review, and no device or additional patient information was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
|
The article "analysis of incidence and reasons for re-intervention after aortic valve replacement using the trifecta aortic bioprosthesis" was reviewed.This research article is a prospective multicentre experience to evaluate the perioperative patient and operative characteristics, and re-intervention rates and survival of patients undergoing surgical implantation of the trifecta and trifecta gt aortic bioprostheses in our center over a 10-year period.The trifecta and trifecta gt aortic bioprosthesis were involved in this study.The conclusion of this study was the trifecta valve had a 1.4% all-cause re-intervention rate at 10 years, with insignificant impact on survival.The primary author is [amir fard, md, university of glasgow, glasgow, uk, the corresponding author is [nawwar al-attar, professor, golden jubilee national hospital, agamemnon street, clydebank, g81 4dy, uk, nawwar.Alattar@gjnh.Scot.Nhs.Uk].
|